6th SSO ASM Lung  Track – Afatinib for the  Treatment of NSCLC with Uncommon EGFR Mutations
Speaker: Prof John Wen-Cheng Chang
Document ID: PC-SG-101262
Listen to Dr John Wen-Cheng CHANG talk about current and next-generation EGFR-TKIs and their efficacy (ORR, PFS) against uncommon EGFR mutations such as Gly719Xaa, Leu861Gln, and Ser768Ile.
Speaker

John Wen-Cheng Chang, MD

Attending Physician, Associate Professor
Division of Hematology-Oncology, Department of Internal Medicine,
Chang Gung Memorial Hospital-Linkou Branch
Taoyuan, Taiwan